Trial intelligence / Profile preview

IM Midazolam vs IV Diazepam for Acute Seizure in Children

NCT06271096Phase 1Completed

Start
Nov 2019
Primary completion
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of midazolam in epilepsy (2 arms). Primary endpoint: Fits Controlled. Started Nov 2019; status: completed.

02

Drugs

midazolam
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT06271096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06271096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call